Prostate cancer screening: weighing the benefits and harms

IF 13.6 1区医学 Q1 UROLOGY & NEPHROLOGY

Nature Reviews Urology Pub Date : 2026-03-06 DOI:10.1038/s41585-026-01133-y

Nikhil Mayor, Hashim U. Ahmed

引用次数: 0

Abstract

The UK’s National Screening Committee recently recommended against population-level prostate cancer screening. Calls to override this guidance are intensifying, but acting without robust evidence might risk exposing thousands of men to unnecessary harm. Data-driven policy changes are crucial.

查看原文本刊更多论文

前列腺癌筛查：利弊权衡。

英国国家筛查委员会最近建议不要进行人群水平的前列腺癌筛查。要求推翻这一指导方针的呼声正在加剧，但在没有有力证据的情况下采取行动可能会使成千上万的男性面临不必要的伤害。数据驱动的政策变化至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Urology 医学-泌尿学与肾脏学

CiteScore

12.50

自引率

2.60%

发文量

123

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Urology is part of the Nature Reviews portfolio of journals.Nature Reviews' basic, translational and clinical content is written by internationally renowned basic and clinical academics and researchers. This journal targeted readers in the biological and medical sciences, from the postgraduate level upwards, aiming to be accessible to professionals in any biological or medical discipline. The journal features authoritative In-depth Reviews providing up-to-date information on topics within a field's history and development. Perspectives, News & Views articles, and the Research Highlights section offer topical discussions and opinions, filtering primary research from various medical journals. Covering a wide range of subjects, including andrology, urologic oncology, and imaging, Nature Reviews provides valuable insights for practitioners, researchers, and academics within urology and related fields.